diclofenac sodium topical / Generic mfg. |
2006-000815-24: A randomized study of topical 3% Diclofenac in a 2.5% Hyaluronate base (Solaraze® 3% Gel) versus topical 5% 5-Fluorouracil (Efudix® Cream) versus liquid nitrogen spray cryotherapy in immunosufficient patients with actinic keratoses– a single center study |
|
|
| Ongoing | 4 | 75 | Europe | Solaraze® 3% Gel, Efudix® Cream, 42752.00.00, 6029133.00.00, | Charité | Actinic keratosis | | | | |
2013-000110-37: Clinical effectiveness and effect on COX-2 expression of the sequential treatment of actinic keratoses (AK) with photodynamic therapy (PDT) and diclofenac 3% gel: a phase IV clinical trial Efectividad clínica y efecto sobre la expresión de COX-2 del tratamiento secuencial de queratosis actínicas con terapia fotodinámica y diclofenaco gel 3%. Ensayo clínico fase IV |
|
|
| Ongoing | 4 | 130 | Europe | SOLARAZE, SOLARAZE | Fundacion para la investigación biomédica del hospital Ramón y Cajal de Madrid, FIS 2012 | Actinic keratosis Queratosis actínica | | | | |
2015-005240-33: A single centre, randomised, single blind, parallel group single dose study to compare the speed of onset of ibuprofen gel, ibuprofen gel with levomenthol and diclofenac gel in the relief of pain from strains, sprains and sports injuries |
|
|
| Ongoing | 4 | 180 | Europe | Deep Relief, Voltarol Pain-eze emulgel, Ibuprofen 5% w/w Gel, Gel, Deep Relief Pain Relief Gel, Voltarol Pain-eze Emulgel, Ibuprofen 5% w/w Gel | The Mentholatum Company Ltd, The Mentholatum Company Ltd | Pain of strains, sprains and sports injuries, Pain of strains, sprains and sports injuries, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT05387525: A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp |
|
|
| Recruiting | 4 | 450 | Europe | Tirbanibulin (Klisyri®) 10 mg/g ointment, Klisyri®, Diclofenac Sodium 3% Gel | Almirall, S.A. | Keratosis, Actinic | 03/27 | 03/27 | | |
2014-002279-27: A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Three-Arm, Multi-Site Study to Evaluate the Clinical Equivalence of Diclofenac Sodium Topical Gel 1% (Hi-Tech Pharmacal Co., Inc.) with Voltaren® Gel (Diclofenac Sodium Topical Gel) 1%(Novartis) in Patients with Osteoarthritis of the Knee. |
|
|
| | 3 | 200 | Europe | Diclofenac Sodium Topical Gel 1%, Voltaren® Gel, Voltaren® Gel, Voltaren® Gel | Hi-Tech Pharmacal Co., Inc., Hi-Tech Pharmacal Co., Inc. | osteoarthritis of the knee | | | | |
| Completed | 3 | 631 | Europe | Solcera, Placebo, Solaraze | Infectopharm Arzneimittel GmbH, Gesellschaft für Therapieforschung mbH | Actinic Keratosis | 01/23 | 01/23 | | |
| Recruiting | 3 | 50 | US | Diclofenac 1% Topical, Petroleum Jelly | Loma Linda University | Cervicogenic Headache | 06/25 | 06/25 | | |
NCT04511195: Effectiveness and Safety of Sphaeralcea Angustifolia Standardized Extract as a Topical Treatment of Knee Osteoarthritis |
|
|
| Recruiting | 2 | 100 | RoW | Standardized extract of Sphaeralcea angustifolia, Sphaeralcea angustifolia standardized extract, Diclofenac Sodium Gel, Diclofenac | Coordinación de Investigación en Salud, Mexico | Knee Osteoarthritis | 01/21 | 06/21 | | |
NCT04091022: Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer |
|
|
| Active, not recruiting | 2 | 138 | US | Solaraze and Vaniqa, Solaraze-topical diclofenac 3% and Vaniqa-topical eflornithine hydrochloride Cream, 13.9% | University of Alabama at Birmingham, National Institutes of Health (NIH), National Cancer Institute (NCI) | Non-melanoma Skin Cancer | 11/24 | 12/24 | | |
| Active, not recruiting | 1 | 36 | RoW | Diclofenac 1%, Diclofenac 3%, Placebo | Daré Bioscience, Inc. | Dysmenorrhea Primary | 09/23 | 05/24 | | |
NCT04402047: Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis |
|
|
| Recruiting | N/A | 108 | RoW | Electroacupuncture, Topical diclofenac sodium gel | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Hand Osteoarthritis | 08/22 | 02/23 | | |